The Covid pandemic and its repercussions have changed the pharmaceutical industry and the healthcare markets. Richard Stedman, the CEO of ACG Engineering, discusses the...

The biopharmaceutical industry is experiencing a drive towards biologic products due to their promise as treatments for chronic diseases.

Interview with Alban Chesneau and Nicolas Castet, Carbon Waters

In response to the urgent need for sustainable solutions in the ­surfactants industry, companies like Locus Ingredients are developing environmentally friendly...

Contract development and manufacturing organizations (CDMOs) are a crucial part of the life sciences industry. Strangely, despite its current prominence, the CDMO...

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...

In its latest European Chemicals Pulse Check, Deloitte surveyed senior executives in the European chemical industry and industry associations about their views on current...